Super-refractory status epilepticus

A therapeutic challenge in paediatrics

Shrikiran Aroor, Kanaparthi Shravan, Suneel C. Mundkur, C. Jayakrishnan, Sai Sripad Rao

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A status epilepticus which persists for 24 hours or more after starting treatment with anaesthesia or has recurred inspite of general anesthesia is known as Super-Refractory Status Epilepticus (SRSE). It includes cases where status epilepticus recurs on reduction or withdrawal of anaesthesia. SRSE, though infrequently seen, constitutes a medical emergency due to the associated high morbidity and mortality. No clear cut guidelines are available till date for the management of SRSE. Most of the published literature was case reports and expert opinion. We hereby reported three cases of super refractory seizures as they posed a therapeutic challenge. All three children were aged 6-7 years with prior normal developmental history and no medical illness. Viral meningoencephalitis, fever induced refractory status epilepticus, and auto-immune encephalitis was the probable aetiology in the cases studied. Midazolam, pentobarbital, and ketamine are the most commonly used anaesthetic agents. Phenytoin, phenobarbitone, valproate and levetiracetam are the most commonly used antiepileptic agents. All three cases had residual neurological deficits and morbidities like pneumonia and sepsis. SRSE is associated with high rates of mortality and morbidity necessitating immediate treatment.

Original languageEnglish
Pages (from-to)SR01-SR04
JournalJournal of Clinical and Diagnostic Research
Volume11
Issue number8
DOIs
Publication statusPublished - 01-08-2017

Fingerprint

Pediatrics
Status Epilepticus
Refractory materials
etiracetam
Morbidity
Therapeutics
Anesthesia
Midazolam
Ketamine
Valproic Acid
Phenytoin
Pentobarbital
Phenobarbital
Meningoencephalitis
Mortality
Anticonvulsants
Expert Testimony
Encephalitis
Anesthetics
General Anesthesia

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

Aroor, Shrikiran ; Shravan, Kanaparthi ; Mundkur, Suneel C. ; Jayakrishnan, C. ; Rao, Sai Sripad. / Super-refractory status epilepticus : A therapeutic challenge in paediatrics. In: Journal of Clinical and Diagnostic Research. 2017 ; Vol. 11, No. 8. pp. SR01-SR04.
@article{f97691c1d584439f9beb2d6c4d485377,
title = "Super-refractory status epilepticus: A therapeutic challenge in paediatrics",
abstract = "A status epilepticus which persists for 24 hours or more after starting treatment with anaesthesia or has recurred inspite of general anesthesia is known as Super-Refractory Status Epilepticus (SRSE). It includes cases where status epilepticus recurs on reduction or withdrawal of anaesthesia. SRSE, though infrequently seen, constitutes a medical emergency due to the associated high morbidity and mortality. No clear cut guidelines are available till date for the management of SRSE. Most of the published literature was case reports and expert opinion. We hereby reported three cases of super refractory seizures as they posed a therapeutic challenge. All three children were aged 6-7 years with prior normal developmental history and no medical illness. Viral meningoencephalitis, fever induced refractory status epilepticus, and auto-immune encephalitis was the probable aetiology in the cases studied. Midazolam, pentobarbital, and ketamine are the most commonly used anaesthetic agents. Phenytoin, phenobarbitone, valproate and levetiracetam are the most commonly used antiepileptic agents. All three cases had residual neurological deficits and morbidities like pneumonia and sepsis. SRSE is associated with high rates of mortality and morbidity necessitating immediate treatment.",
author = "Shrikiran Aroor and Kanaparthi Shravan and Mundkur, {Suneel C.} and C. Jayakrishnan and Rao, {Sai Sripad}",
year = "2017",
month = "8",
day = "1",
doi = "10.7860/JCDR/2017/25811.10485",
language = "English",
volume = "11",
pages = "SR01--SR04",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "8",

}

Super-refractory status epilepticus : A therapeutic challenge in paediatrics. / Aroor, Shrikiran; Shravan, Kanaparthi; Mundkur, Suneel C.; Jayakrishnan, C.; Rao, Sai Sripad.

In: Journal of Clinical and Diagnostic Research, Vol. 11, No. 8, 01.08.2017, p. SR01-SR04.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Super-refractory status epilepticus

T2 - A therapeutic challenge in paediatrics

AU - Aroor, Shrikiran

AU - Shravan, Kanaparthi

AU - Mundkur, Suneel C.

AU - Jayakrishnan, C.

AU - Rao, Sai Sripad

PY - 2017/8/1

Y1 - 2017/8/1

N2 - A status epilepticus which persists for 24 hours or more after starting treatment with anaesthesia or has recurred inspite of general anesthesia is known as Super-Refractory Status Epilepticus (SRSE). It includes cases where status epilepticus recurs on reduction or withdrawal of anaesthesia. SRSE, though infrequently seen, constitutes a medical emergency due to the associated high morbidity and mortality. No clear cut guidelines are available till date for the management of SRSE. Most of the published literature was case reports and expert opinion. We hereby reported three cases of super refractory seizures as they posed a therapeutic challenge. All three children were aged 6-7 years with prior normal developmental history and no medical illness. Viral meningoencephalitis, fever induced refractory status epilepticus, and auto-immune encephalitis was the probable aetiology in the cases studied. Midazolam, pentobarbital, and ketamine are the most commonly used anaesthetic agents. Phenytoin, phenobarbitone, valproate and levetiracetam are the most commonly used antiepileptic agents. All three cases had residual neurological deficits and morbidities like pneumonia and sepsis. SRSE is associated with high rates of mortality and morbidity necessitating immediate treatment.

AB - A status epilepticus which persists for 24 hours or more after starting treatment with anaesthesia or has recurred inspite of general anesthesia is known as Super-Refractory Status Epilepticus (SRSE). It includes cases where status epilepticus recurs on reduction or withdrawal of anaesthesia. SRSE, though infrequently seen, constitutes a medical emergency due to the associated high morbidity and mortality. No clear cut guidelines are available till date for the management of SRSE. Most of the published literature was case reports and expert opinion. We hereby reported three cases of super refractory seizures as they posed a therapeutic challenge. All three children were aged 6-7 years with prior normal developmental history and no medical illness. Viral meningoencephalitis, fever induced refractory status epilepticus, and auto-immune encephalitis was the probable aetiology in the cases studied. Midazolam, pentobarbital, and ketamine are the most commonly used anaesthetic agents. Phenytoin, phenobarbitone, valproate and levetiracetam are the most commonly used antiepileptic agents. All three cases had residual neurological deficits and morbidities like pneumonia and sepsis. SRSE is associated with high rates of mortality and morbidity necessitating immediate treatment.

UR - http://www.scopus.com/inward/record.url?scp=85028369536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028369536&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2017/25811.10485

DO - 10.7860/JCDR/2017/25811.10485

M3 - Article

VL - 11

SP - SR01-SR04

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 8

ER -